SEC Form D · filed June 9, 2022
Code Biotherapeutics, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Robert C. Getts · Hatfield, PAExecVictor C. Stone · Hatfield, PADirectorBrian Mcveigh · Hatfield, PAExec · DirectorEdward C. Mathers · Hatfield, PADirectorDmitry C. Kuzmin · Hatfield, PADirectorLauren C. Kaskiel · Hatfield, PAExecRuss Fein · Hatfield, PAExec · DirectorJoseph Truitt · Hatfield, PADirectorKathy Rouan · Hatfield, PADirectorRobert C. Lin · Hatfield, PADirectorShane Barratt · New York, NYExecPaul Lucek · Rye Brook, NYDirectorSamuel G. Sawhook · Corpus Christi, TXExecRoshun Patel · New York, NYDirectorFrank P. Savage · New York, NYDirectorDerek P. Watson · New York, NYDirectorMichael Abbott · New York, NYExec · DirectorJoseph Beach · Denver, COExec · DirectorLarissa Belova · ATLANTA, GADirectorMichael Jordan · New York, NYDirectorErin C. Brubaker · Hatfield, PAExecCarole Spangler Vaughn · Spring, TXDirectorMartin Simonetti · Scottsdale, AZDirectorAnn Tanabe · Houston, TXExec · DirectorAnthony Mallin · London, United KingdomExec · DirectorAdolfo F. Henriques · Hollywood, FLDirectorFrank J. Schwitter · Hollywood, FLDirectorMark H. Hildebrandt · Hollywood, FLExecJulie H. Neitzel · Hollywood, FLExecCarlos L. Macau, Jr · Hollywood, FLDirectorAlan H. Schriesheim · Hollywood, FLDirectorErin C. Brubaker · Hatfield, PAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗